The Dr. Tyna Show cover image

GLP-1 Agonists and the Gut Microbiome: Unveiling Their Role in Metabolic Health | Solo Episode

The Dr. Tyna Show

00:00

Exploring the Impact of GLP-1 Agonists on Gut Microbiome and Metabolic Health

This chapter explores the effects of GLP-1 agonist dulaclutide on the gut microbiome in type 2 diabetes patients. It highlights research showing how long-term use can modify intestinal flora, linking these changes to improved metabolic health markers.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app